U.S., Feb. 25 -- ClinicalTrials.gov registry received information related to the study (NCT06842654) titled 'EORTC Quality of Life Measurement Strategies in Progressive Cancer' on Feb. 18.
Brief Summary: Rationale: Health-related quality of life (HRQOL) in people diagnosed with cancer is of increasing interest as an endpoint in clinical care and research. It helps keep track of patients' functioning and wellbeing, and informs the net clinical benefit of treatment. However, gathering HRQOL information becomes increasingly harder when patients experience disease progression. Therefore we need to develop measurement strategies of HRQOL within the progressive disease setting. Objective: The overall aim of the project is to develop recommendati...